Biocept, Inc. (NASDAQ:BIOC) went down by -4.59% from its latest closing price when compared to the 1-year high value of $4.20 and move down -303.85%, while BIOC stocks collected +2.97% of gains with the last five trading sessions.

Biocept, Inc. (NASDAQ:BIOC) Worth an Investment?

Biocept, Inc. (NASDAQ: BIOC) The 36 Months beta value for BIOC stocks is at 1.98, while 1 of the analysts out of 1 who provided ratings for Biocept, Inc. stocks as a “buy” while 0 as overweight, 0 rated it as hold and 0 as sell. The average price we get from analysts is $3.00 which is $3.38 above current price. BIOC currently has a short float of 5.77% and public float of 11.58M with average trading volume of 3.60M shares.

BIOC Market Performance

BIOC stocks went up by 2.97% for the week, with the monthly drop of -0.95% and a quarterly performance of 22.35%, while its annual performance rate touched -74.13%. The simple moving average for the period of the last 20 days is 0.92% for BIOC stocks with the simple moving average of -14.93% for the last 200 days.

BIOC Stocks -1.03% Far from 50 Day Moving Average

After a stumble in the market that brought BIOC to its low price for the period of the last 52 weeks, Biocept, Inc. was unable to take a rebound, for now settling with -75.24% of loss for the given period.

The stock volatility was left at 3.84%, however, within the period of a single month, the volatility rate increased by 3.55%, while the shares sank at the distance of -1.89% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -12.61% lower at the present time.

In the course of the last 5 trading sessions, BIOC went up by +2.97%, which changed the moving average for the period of 200 days to the total of -50.94% of losses for the stock in comparison to the 20-day moving average settled at $1.03. In addition, Biocept, Inc. saw 20.92% in overturn over the period of a single year with a tendency to cut further gains.

BIOC Stock Fundamentals

The current profitability levels are settled at -746.35 for the present operating margin and -209.26 for gross margin. The net margin for Biocept, Inc. stands at -755.98. Total capital return value is set at -554.22, while invested capital returns managed to touch -759.13. Equity return holds the value -348.70%, with -186.00% for asset returns.

Based on Biocept, Inc. (BIOC), the company’s capital structure generated 53.46 points for debt to equity in total, while total debt to capital is set at the value of 34.84. Total debt to assets is settled at the value of 18.59 with long-term debt to equity ratio rests at 32.37 and long-term debt to capital is 21.10.

The value for Enterprise to Sales is 10.54 with debt to enterprise value settled at 2.67. The receivables turnover for Biocept, Inc. is 2.35 with the total asset turnover at the value of 0.40. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.30.